Epithelial-mesenchymal transition (EMT) is involved in a variety of tissue fibroses. Fibroblasts/myofibroblasts derived from epithelial cells contribute to the excessive accumulation of fibrous connective tissue in damaged tissue, which can lead to permanent scarring or organ malfunction. Therefore, EMT-related fibrosis cannot be neglected. This review highlights the findings that demonstrate the EMT to be a direct contributor to the fibroblast/myofibroblast population in the development of tissue fibrosis and helps to elucidate EMT-related anti-fibrotic strategies, which may enable the development of therapeutic interventions to suppress EMT and potentially reverse organ fibrosis.
CampanholleGLigrestiGGharibSADuffieldJS. Cellular mechanisms of tissue fibrosis. 3. Novel mechanisms of kidney fibrosis. Am J Physiol Cell Physiol2013; 304: C591–603.
2.
XueZFWuXMLiuM. Hepatic regeneration and the epithelial to mesenchymal transition. World J Gastroenterol2013; 19: 1380–6.
3.
MicallefLVedrenneNBilletFCoulombBDarbyIADesmouliereA. The myofibroblast, multiple origins for major roles in normal and pathological tissue repair. Fibrogenesis Tissue Repair2012; 5(Suppl 1 Proceedings of fibroproliferative disorders: from biochemical analysis to targeted therapies Petro E Petrides and David Brenner): S5–S5.
4.
KalluriRWeinbergRA. The basics of epithelial-mesenchymal transition. J Clin Invest2009; 119: 1420–8.
5.
SaitohMMiyazawaK. Transcriptional and post-transcriptional regulation in TGF-beta-mediated epithelial-mesenchymal transition. J Biochem2012; 151: 563–71.
6.
HuangRYGuilfordPThieryJP. Early events in cell adhesion and polarity during epithelial-mesenchymal transition. J Cell Sci2012; 125(Pt 19): 4417–22.
7.
LorussoGRueggC. The tumor microenvironment and its contribution to tumor evolution toward metastasis. Histochem Cell Biol2008; 130: 1091–103.
8.
ZavadilJBottingerEP. TGF-beta and epithelial-to-mesenchymal transitions. Oncogene2005; 24: 5764–74.
9.
CarewRMWangBKantharidisP. The role of EMT in renal fibrosis. Cell Tissue Res2012; 347: 103–16.
XuDZhangTChenXZhouQLiuCDengZZhangLYingCZhangWGuM. Reduction of osteopontin in vivo inhibits tubular epithelial to mesenchymal transition in rats with chronic allograft nephropathy. Transplant Proc2013; 45: 659–65.
19.
XueHXiaoZZhangJWenJWangYChangZZhaoJGaoXDuJChenYG. Disruption of the Dapper3 gene aggravates ureteral obstruction-mediated renal fibrosis by amplifying Wnt/beta-catenin signaling. J Biol Chem2013; 288: 15006–14.
DeMaioLBuckleySTKrishnaveniMSFlodbyPDubourdMBanfalviAXingYEhrhardtCMinooPZhouBCrandallEDBorokZ. Ligand-independent transforming growth factor-beta type I receptor signalling mediates type I collagen-induced epithelial-mesenchymal transition. J Pathol2012; 226: 633–44.
24.
SchneiderDJWuMLeTTChoSHBrennerMBBlackburnMRAgarwalSK. Cadherin-11 contributes to pulmonary fibrosis: potential role in TGF-beta production and epithelial to mesenchymal transition. FASEB J2012; 26: 503–12.
25.
StrutzFOkadaHLoCWDanoffTCaroneRLTomaszewskiJENeilsonEG. Identification and characterization of a fibroblast marker: FSP1. J Cell Biol1995; 130: 393–405.
26.
DuanSBLiuGLWangYHZhangJJ. Epithelial-to-mesenchymal transdifferentiation of renal tubular epithelial cell mediated by oxidative stress and intervention effect of probucol in diabetic nephropathy rats. Ren Fail2012; 34: 1244–51.
27.
MacaryGRossertJBrunevalPMandetCBelairMFHouillierPDuong Van HuyenJP. Transgenic mice expressing nitroreductase gene under the control of the podocin promoter: a new murine model of inductible glomerular injury. Virchows Arch2010; 456: 325–37.
28.
NgYYHuangTPYangWCChenZPYangAHMuWNikolic-PatersonDJAtkinsRCLanHY. Tubular epithelial-myofibroblast transdifferentiation in progressive tubulointerstitial fibrosis in 5/6 nephrectomized rats. Kidney Int1998; 54: 864–76.
29.
YangJLiuY. Dissection of key events in tubular epithelial to myofibroblast transition and its implications in renal interstitial fibrosis. Am J Pathol2001; 159: 1465–75.
30.
YangJLiuY. Blockage of tubular epithelial to myofibroblast transition by hepatocyte growth factor prevents renal interstitial fibrosis. J Am Soc Nephrol2002; 13: 96–107.
Meindl-BeinkerNMDooleyS. Transforming growth factor-beta and hepatocyte transdifferentiation in liver fibrogenesis. J Gastroenterol Hepatol2008; 23(Suppl 1): S122–7.
33.
SynWKJungYOmenettiAAbdelmalekMGuyCDYangLWangJWitekRPFearingCMPereiraTATeaberryVChoiSSConde-VancellsJKaracaGFDiehlAM. Hedgehog-mediated epithelial-to-mesenchymal transition and fibrogenic repair in nonalcoholic fatty liver disease. Gastroenterology2009; 137: 1478–88 e8.
34.
KimKKKuglerMCWoltersPJRobillardLGalvezMGBrumwellANSheppardDChapmanHA. Alveolar epithelial cell mesenchymal transition develops in vivo during pulmonary fibrosis and is regulated by the extracellular matrix. Proc Natl Acad Sci USA2006; 103: 13180–5.
35.
WuZYangLCaiLZhangMChengXYangXXuJ. Detection of epithelial to mesenchymal transition in airways of a bleomycin induced pulmonary fibrosis model derived from an alpha-smooth muscle actin-Cre transgenic mouse. Respir Res2007; 8: 1–1.
36.
TanjoreHXuXCPolosukhinVVDegryseALLiBHanWSherrillTPPliethDNeilsonEGBlackwellTSLawsonWE. Contribution of epithelial-derived fibroblasts to bleomycin-induced lung fibrosis. Am J Respir Crit Care Med2009; 180: 657–65.
37.
ZeisbergMYangCMartinoMDuncanMBRiederFTanjoreHKalluriR. Fibroblasts derive from hepatocytes in liver fibrosis via epithelial to mesenchymal transition. J Biol Chem2007; 282: 23337–47.
38.
NadasdyTLaszikZBlickKEJohnsonDLSilvaFG. Tubular atrophy in the end-stage kidney: a lectin and immunohistochemical study. Human Pathol1994; 25: 22–8.
39.
JindeKNikolic-PatersonDJHuangXRSakaiHKurokawaKAtkinsRCLanHY. Tubular phenotypic change in progressive tubulointerstitial fibrosis in human glomerulonephritis. Am J Kidney Dis2001; 38: 761–9.
40.
RastaldiMPFerrarioFGiardinoLDell'AntonioGGrilloCGrilloPStrutzFMullerGAColasantiGD'AmicoG. Epithelial-mesenchymal transition of tubular epithelial cells in human renal biopsies. Kidney Int2002; 62: 137–46.
41.
NishitaniYIwanoMYamaguchiYHaradaKNakataniKAkaiYNishinoTShiikiHKanauchiMSaitoYNeilsonEG. Fibroblast-specific protein 1 is a specific prognostic marker for renal survival in patients with IgAN. Kidney Int2005; 68: 1078–85.
42.
VongwiwatanaATasanarongARaynerDCMelkAHalloranPF. Epithelial to mesenchymal transition during late deterioration of human kidney transplants: the role of tubular cells in fibrogenesis. Am J Transplant2005; 5: 1367–74.
43.
HaradaTNabeshimaKHamasakiMUesugiNWatanabeKIwasakiH. Epithelial-mesenchymal transition in human lungs with usual interstitial pneumonia: quantitative immunohistochemistry. Pathol Int2010; 60: 14–21.
44.
WardCForrestIAMurphyDMJohnsonGERobertsonHCawstonTEFisherAJDarkJHLordanJLKirbyJACorrisPA. Phenotype of airway epithelial cells suggests epithelial to mesenchymal cell transition in clinically stable lung transplant recipients. Thorax2005; 60: 865–71.
45.
WillisBCLieblerJMLuby-PhelpsKNicholsonAGCrandallEDdu BoisRMBorokZ. Induction of epithelial-mesenchymal transition in alveolar epithelial cells by transforming growth factor-beta1: potential role in idiopathic pulmonary fibrosis. Am J Pathol2005; 166: 1321–32.
46.
MilaraJPeiroTSerranoACortijoJ. Epithelial to mesenchymal transition is increased in patients with COPD and induced by cigarette smoke. Thorax2013; 68: 410–20.
47.
DengYHPuCLLiYCZhuJXiangCZhangMMGuoCB. Analysis of biliary epithelial-mesenchymal transition in portal tract fibrogenesis in biliary atresia. Dig Dis Sci2011; 56: 731–40.
48.
RygielKARobertsonHMarshallHLPekalskiMZhaoLBoothTAJonesDEBurtADKirbyJA. Epithelial-mesenchymal transition contributes to portal tract fibrogenesis during human chronic liver disease. Lab Invest2008; 88: 112–23.
49.
DooleySHamzaviJCiuclanLGodoyPIlkavetsIEhnertSUeberhamEGebhardtRKanzlerSGeierABreitkopfKWengHMertensPR. Hepatocyte-specific Smad7 expression attenuates TGF-beta-mediated fibrogenesis and protects against liver damage. Gastroenterology2008; 135: 642–59.
HumphreysBDLinSLKobayashiAHudsonTENowlinBTBonventreJVValeriusMTMcMahonAPDuffieldJS. Fate tracing reveals the pericyte and not epithelial origin of myofibroblasts in kidney fibrosis. Am J Pathol2010; 176: 85–97.
52.
ChuASDiazRHuiJJYangerKZongYAlpiniGStangerBZWellsRG. Lineage tracing demonstrates no evidence of cholangiocyte epithelial-to-mesenchymal transition in murine models of hepatic fibrosis. Hepatology2011; 53: 1685–95.
53.
TauraKMiuraKIwaisakoKOsterreicherCHKodamaYPenz-OsterreicherMBrennerDA. Hepatocytes do not undergo epithelial-mesenchymal transition in liver fibrosis in mice. Hepatology2010; 51: 1027–36.
54.
HertigAAnglicheauDVerineJPalletNTouzotMAncelPYMesnardLBrousseNBaugeyEGlotzDLegendreCRondeauEXu-DuboisYC. Early epithelial phenotypic changes predict graft fibrosis. J Am Soc Nephrol2008; 19: 1584–91.
55.
BloomABZamanMH. Influence of the microenvironment on cell fate determination and migration. Physiol Genomics2014; 46: 309–14.
56.
Movahednia MM, Kidwai FK, Zou Y, Tong HJ, Liu X, Islam I, Toh WS, Raghunath M, Cao T. Differential effects of the extracellular microenvironment on human embryonic stem cells differentiation into keratinocytes and their subsequent replicative lifespan. Tissue Eng Part A 2015; 21:1432–43.
57.
KimKKWeiYSzekeresCKuglerMCWoltersPJHillMLFrankJABrumwellANWheelerSEKreidbergJAChapmanHA. Epithelial cell alpha3beta1 integrin links beta-catenin and Smad signaling to promote myofibroblast formation and pulmonary fibrosis. J Clin Invest2009; 119: 213–24.
58.
MackinnonACGibbonsMAFarnworthSLLefflerHNilssonUJDelaineTSimpsonAJForbesSJHiraniNGauldieJSethiT. Regulation of transforming growth factor-beta1-driven lung fibrosis by galectin-3. Am J Respir Crit Care Med2012; 185: 537–46.
59.
ZhaoHDongYTianXTanTKLiuZZhaoYZhangYHarrisDZhengG. Matrix metalloproteinases contribute to kidney fibrosis in chronic kidney diseases. World J Nephrol2013; 2: 84–9.
60.
ChengSLovettDH. Gelatinase A (MMP-2) is necessary and sufficient for renal tubular cell epithelial-mesenchymal transformation. Am J Pathol2003; 162: 1937–49.
61.
LiuY. Epithelial to mesenchymal transition in renal fibrogenesis: pathologic significance, molecular mechanism, and therapeutic intervention. J Am Soc Nephrol2004; 15: 1–12.
62.
TanTKZhengGHsuTTWangYLeeVWTianXWangYCaoQWangYHarrisDC. Macrophage matrix metalloproteinase-9 mediates epithelial-mesenchymal transition in vitro in murine renal tubular cells. Am J Pathol2010; 176: 1256–70.
63.
ZeisbergMBonnerGMaeshimaYColoradoPMullerGAStrutzFKalluriR. Renal fibrosis: collagen composition and assembly regulates epithelial-mesenchymal transdifferentiation. Am J Pathol2001; 159: 1313–21.
64.
ImamichiYMenkeA. Signaling pathways involved in collagen-induced disruption of the E-cadherin complex during epithelial-mesenchymal transition. Cells Tissues Organs2007; 185: 180–90.
65.
Loeffler I, Liebisch M, Wolf G. Collagen VIII influences epithelial phenotypic changes in experimental diabetic nephropathy. Am J Physiol Renal Physiol 2012;303(5):F733–45.
RunyanCEHayashidaTHubchakSCurleyJFSchnaperHW. Role of SARA (SMAD anchor for receptor activation) in maintenance of epithelial cell phenotype. J Biol Chem2009; 284: 25181–9.
Strutz F, Zeisberg M, Ziyadeh FN, Yang CQ, Kalluri R, Müller GA, Neilson EG. Role of basic fibroblast growth factor-2 in epithelial-mesenchymal transformation. Kidney Int 2002;61(5):1714–28.
73.
MasolaVGambaroGTibaldiEBrunatiAMGastaldelloAD'AngeloAOnistoMLupoA. Heparanase and syndecan-1 interplay orchestrates fibroblast growth factor-2-induced epithelial-mesenchymal transition in renal tubular cells. J Biol Chem2012; 287: 1478–88.
BorthwickLACorrisPAMahidaRWalkerAGardnerASuwaraMJohnsonGEMoiseyEJBrodlieMWardCPerryJDDe SoyzaAMannDAFisherAJ. TNFalpha from classically activated macrophages accentuates epithelial to mesenchymal transition in obliterative bronchiolitis. Am J Transplant2013; 13: 621–33.
76.
KamitaniSYamauchiYKawasakiSTakamiKTakizawaHNagaseTKohyamaT. Simultaneous stimulation with TGF-beta1 and TNF-alpha induces epithelial mesenchymal transition in bronchial epithelial cells. Int Arch Allergy Immunol2011; 155: 119–28.
77.
DoernerAMZurawBL. TGF-beta1 induced epithelial to mesenchymal transition (EMT) in human bronchial epithelial cells is enhanced by IL-1beta but not abrogated by corticosteroids. Respir Res2009; 10: 100–100.
78.
JiXLiJXuLWangWLuoMLuoSMaLLiKGongSHeLZhangZYangPZhouZXiangXWangCY. IL4 and IL-17A provide a Th2/Th17-polarized inflammatory milieu in favor of TGF-beta1 to induce bronchial epithelial-mesenchymal transition (EMT). Int J Clin Exp Pathol2013; 6: 1481–92.
79.
JohnsonJRNishiokaMChakirJRissePAAlmaghlouthIBazarbashiANPlanteSMartinJGEidelmanDHamidQ. IL-22 contributes to TGF-beta1-mediated epithelial-mesenchymal transition in asthmatic bronchial epithelial cells. Respir Res2013; 14: 118–118.
80.
XiongMGongJLiuYXiangRTanX. Loss of vitamin D receptor in chronic kidney disease: a potential mechanism linking inflammation to epithelial-to-mesenchymal transition. Am J Physiol Ren Physiol2012; 303: F1107–15.
81.
RicardoSDvan GoorHEddyAA. Macrophage diversity in renal injury and repair. J Clin Invest2008; 118: 3522–30.
82.
RhyuDYYangYHaHLeeGTSongJSUhSTLeeHB. Role of reactive oxygen species in TGF-beta1-induced mitogen-activated protein kinase activation and epithelial-mesenchymal transition in renal tubular epithelial cells. J Am Soc Nephrol2005; 16: 667–75.
83.
DjamaliAReeseSYrachetaJOberleyTHullettDBeckerB. Epithelial-to-mesenchymal transition and oxidative stress in chronic allograft nephropathy. Am J Transplant2005; 5: 500–9.
84.
RosenPNawrothPPKingGMollerWTritschlerHJPackerL. The role of oxidative stress in the onset and progression of diabetes and its complications: a summary of a Congress Series sponsored by UNESCO-MCBN, the American Diabetes Association and the German Diabetes Society. Diabetes/metab Res Rev2001; 17: 189–212.
Thallas-BonkeVThorpeSRCoughlanMTFukamiKYapFYSourrisKCPenfoldSABachLACooperMEForbesJM. Inhibition of NADPH oxidase prevents advanced glycation end product-mediated damage in diabetic nephropathy through a protein kinase C-alpha-dependent pathway. Diabetes2008; 57: 460–9.
87.
HaHLeeHB. Reactive oxygen species amplify glucose signalling in renal cells cultured under high glucose and in diabetic kidney. Nephrology2005; 10(Suppl): S7–10.
88.
FukawaTKajiyaHOzekiSIkebeTOkabeK. Reactive oxygen species stimulates epithelial mesenchymal transition in normal human epidermal keratinocytes via TGF-beta secretion. Exp Cell Res2012; 318: 1926–32.
89.
DjamaliA. Oxidative stress as a common pathway to chronic tubulointerstitial injury in kidney allografts. Am J Physiol Renal Physiol2007; 293: F445–55.
90.
GorowiecMRBorthwickLAParkerSMKirbyJASaretzkiGCFisherAJ. Free radical generation induces epithelial-to-mesenchymal transition in lung epithelium via a TGF-beta1-dependent mechanism. Free Radic Biol Med2012; 52: 1024–32.
91.
LeeKNelsonCM. New insights into the regulation of epithelial-mesenchymal transition and tissue fibrosis. Int Rev Cell Mol Biol2012; 294: 171–221.
92.
YangXChenBLiuTChenX. Reversal of myofibroblast differentiation: a review. Eur J Pharmacol2014; 734: 83–90.
93.
ChenYLZhangXBaiJGaiLYeXLZhangLXuQZhangYXXuLLiHPDingX. Sorafenib ameliorates bleomycin-induced pulmonary fibrosis: potential roles in the inhibition of epithelial-mesenchymal transition and fibroblast activation. Cell Death Dis2013; 4: e665–e665.
94.
ConnollyECFreimuthJAkhurstRJ. Complexities of TGF-beta targeted cancer therapy. Int J Biol Sci2012; 8: 964–78.
95.
KimSGSongJY. Therapeutic targeting of oncogenic transforming growth factor-beta1 signaling by antisense oligonucleotides in oral squamous cell carcinoma. Oncol Rep2012; 28: 539–44.
96.
Hawinkels LJ, Ten Dijke P. Exploring anti-TGF-β therapies in cancer and fibrosis. Growth Factors 2011;29(4):140–52.
97.
YangYWolframJShenHFangXFerrariM. Hesperetin: an inhibitor of the transforming growth factor-beta (TGF-beta) signaling pathway. Eur J Med Chem2012; 58: 390–5.
98.
ParkCYKimDKSheenYY. EW-7203, a novel small molecule inhibitor of transforming growth factor-beta (TGF-beta) type I receptor/activin receptor-like kinase-5, blocks TGF-beta1-mediated epithelial-to-mesenchymal transition in mammary epithelial cells. Cancer Sci2011; 102: 1889–96.
99.
FangYChenYYuLZhengCQiYLiZYangZZhangYShiTLuoJLiuM. Inhibition of breast cancer metastases by a novel inhibitor of TGFbeta receptor 1. J Natl Cancer Inst2013; 105: 47–58.
100.
Dooley S, Hamzavi J, Ciuclan L, Godoy P, Ilkavets I, Ehnert S, Ueberham E, Gebhardt R, Kanzler S, Geier A, Breitkopf K, Weng H, Mertens PR. Hepatocyte-specific Smad7 expression attenuates TGF-beta-mediated fibrogenesis and protects against liver damage. Gastroenterology 2008;135(2):642–59.
101.
HameedaldeenALiuJBatresAGravesGSGravesDT. FOXO1, TGF-beta regulation and wound healing. Int J Mol Sci2014; 15: 16257–69.
102.
PennJWGrobbelaarAORolfeKJ. The role of the TGF-beta family in wound healing, burns and scarring: a review. Int J Burns Trauma2012; 2: 18–28.
103.
GazdharATemuriAKnudsenLGuggerMSchmidRAOchsMGeiserT. Targeted gene transfer of hepatocyte growth factor to alveolar type II epithelial cells reduces lung fibrosis in rats. Human Gene Ther2013; 24: 105–16.
104.
TasanarongAKongkhamSThitiarchakulSEiam-OngS. Vitamin E ameliorates renal fibrosis in ureteral obstruction: role of maintaining BMP-7 during epithelial-to-mesenchymal transition. J Med Assoc Thai2011; 94(Suppl 7): S10–8.
105.
LianYGZhouQGZhangYJZhengFL. VEGF ameliorates tubulointerstitial fibrosis in unilateral ureteral obstruction mice via inhibition of epithelial-mesenchymal transition. Acta Pharm Sinic2011; 32: 1513–21.
106.
ZhangXWangJFanYYangLWangLMaJ. Zinc supplementation attenuates high glucose-induced epithelial-to-mesenchymal transition of peritoneal mesothelial cells. Biol Trace Elem Res2012; 150: 229–35.
107.
PanditKVCorcoranDYousefHYarlagaddaMTzouvelekisAGibsonKFKonishiKYousemSASinghMHandleyDRichardsTSelmanMWatkinsSCPardoABen-YehudahABourosDEickelbergORayPBenosPVKaminskiN. Inhibition and role of let-7d in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med2010; 182: 220–9.
108.
WangBKohPWinbanksCCoughlanMTMcClellandAWatsonAJandeleit-DahmKBurnsWCThomasMCCooperMEKantharidisP. miR-200a prevents renal fibrogenesis through repression of TGF-beta2 expression. Diabetes2011; 60: 280–7.
109.
KriegelAJFangYLiuYTianZMladinovDMatusIRDingXGreeneASLiangM. MicroRNA-target pairs in human renal epithelial cells treated with transforming growth factor beta 1: a novel role of miR-382. Nucleic Acids Res2010; 38: 8338–47.
110.
PogribnyIPStarlard-DavenportATryndyakVPHanTRossSARusynIBelandFA. Difference in expression of hepatic microRNAs miR-29c, miR-34a, miR-155, and miR-200b is associated with strain-specific susceptibility to dietary nonalcoholic steatohepatitis in mice. Lab Invest2010; 90: 1437–46.
111.
ItoYCorrellKSchielJAFiniganJHPrekerisRMasonRJ. Lung fibroblasts accelerate wound closure in human alveolar epithelial cells through hepatocyte growth factor/c-Met signaling. Am J Physiol Lung Cell Mol Physiol2014; 307: L94–105.
112.
LiJFDuanHFWuCTZhangDJDengYYinHLHanBGongHCWangHWWangYL. HGF accelerates wound healing by promoting the dedifferentiation of epidermal cells through beta1-integrin/ILK pathway. BioMed Res Int2013; 2013: 470418–470418.
113.
SuhHNHanHJ. Sonic hedgehog increases the skin wound-healing ability of mouse embryonic stem cells through the microRNA 200 family. Br J Pharmacol2015; 172: 815–28.
114.
DayYJHuangLYeHLindenJOkusaMD. Renal ischemia-reperfusion injury and adenosine 2A receptor-mediated tissue protection: role of macrophages. Am J Physiol Ren Physiol2005; 288: F722–31.
115.
JoSKSungSAChoWYGoKJKimHK. Macrophages contribute to the initiation of ischaemic acute renal failure in rats. Nephrol Dial Transplant2006; 21: 1231–9.
116.
DiamondJRPesek-DiamondI. Sublethal X-irradiation during acute puromycin nephrosis prevents late renal injury: role of macrophages. Am J Physiol1991; 260(6 Pt 2): F779–86.
117.
van GoorHvan der HorstMLFidlerVGrondJ. Glomerular macrophage modulation affects mesangial expansion in the rat after renal ablation. Lab Invest1992; 66: 564–71.
118.
FriedmanSL. Mac the knife? Macrophages- the double-edged sword of hepatic fibrosis. J Clin Invest2005; 115: 29–32.
119.
DuffieldJSTippingPGKipariTCailhierJFClaySLangRBonventreJVHughesJ. Conditional ablation of macrophages halts progression of crescentic glomerulonephritis. Am J Pathol2005; 167: 1207–19.
120.
ChazaudBSonnetCLafustePBassezGRimaniolACPoronFAuthierFJDreyfusPAGherardiRK. Satellite cells attract monocytes and use macrophages as a support to escape apoptosis and enhance muscle growth. J Cell Biol2003; 163: 1133–43.
121.
ArnoldLHenryAPoronFBaba-AmerYvan RooijenNPlonquetAGherardiRKChazaudB. Inflammatory monocytes recruited after skeletal muscle injury switch into antiinflammatory macrophages to support myogenesis. J Exp Med2007; 204: 1057–69.
122.
MiSLiZYangHZLiuHWangJPMaYGWangXXLiuHZSunWHuZW. Blocking IL-17A promotes the resolution of pulmonary inflammation and fibrosis via TGF-beta1-dependent and -independent mechanisms. J Immunol2011; 187: 3003–14.
123.
MiyajimaAKosakaTSetaKAsanoTUmezawaKHayakawaM. Novel nuclear factor kappa B activation inhibitor prevents inflammatory injury in unilateral ureteral obstruction. J Urol2003; 169: 1559–63.
124.
ChitraPSaiprasadGManikandanRSudhandiranG. Berberine attenuates bleomycin induced pulmonary toxicity and fibrosis via suppressing NF-kappaB dependant TGF-beta activation: a biphasic experimental study. Toxicol Lett2013; 219: 178–93.
125.
Lopez-NovoaJMNietoMA. Inflammation and EMT: an alliance towards organ fibrosis and cancer progression. EMBO Mol Med2009; 1: 303–14.
126.
ZhuTZhangWXiaoMChenHJinH. Protective role of andrographolide in bleomycin-induced pulmonary fibrosis in mice. Int J Mol Sci2013; 14: 23581–96.
127.
HinzBGabbianiG. Fibrosis: recent advances in myofibroblast biology and new therapeutic perspectives. F1000 Biol Rep2010; 2: 78–78.
128.
AbeMYokoyamaYIshikawaO. A possible mechanism of basic fibroblast growth factor-promoted scarless wound healing: the induction of myofibroblast apoptosis. Eur J Dermatol2012; 22: 46–53.
129.
MiceraAPuxedduIBalzaminoBOBoniniSLevi-SchafferF. Chronic nerve growth factor exposure increases apoptosis in a model of in vitro induced conjunctival myofibroblasts. PloS One2012; 7: e47316–e47316.
130.
HinzB. Formation and function of the myofibroblast during tissue repair. J Invest Dermatol2007; 127: 526–37.
131.
VedrenneNCoulombBDanigoABonteFDesmouliereA. The complex dialogue between (myo)fibroblasts and the extracellular matrix during skin repair processes and ageing. Pathologie-biologie2012; 60: 20–7.
132.
ZhouYHuangXHeckerLKurundkarDKurundkarALiuHJinTHDesaiLBernardKThannickalVJ. Inhibition of mechanosensitive signaling in myofibroblasts ameliorates experimental pulmonary fibrosis. J Clin Invest2013; 123: 1096–108.
133.
Nunes de CarvalhoSda Cunha LiraDCosta CortezEAde AndradeDCTholeAAStumboACde CarvalhoL. Bone marrow cell transplantation is associated with fibrogenic cells apoptosis during hepatic regeneration in cholestatic rats. Biochem Cell Biol2013; 91: 88–94.
134.
DouglassAWallaceKKoruthMBarelleCPorterAJWrightMC. Targeting liver myofibroblasts: a novel approach in anti-fibrogenic therapy. Hepatol Int2008; 2: 405–15.
135.
BrownKAAakreMEGorskaAEPriceJOEltomSEPietenpolJAMosesHL. Induction by transforming growth factor-beta1 of epithelial to mesenchymal transition is a rare event in vitro. Breast Cancer Res2004; 6: R215–31.
136.
ShuklaMNRoseJLRayRLathropKLRayARayP. Hepatocyte growth factor inhibits epithelial to myofibroblast transition in lung cells via Smad7. Am J Respir Cell Mol Biol2009; 40: 643–53.
137.
AroraPAnsariSNazishI. Study of antiobesity effects of ethanolic and water extracts of grapes seeds. J Complement Integr Med2011; 8.
138.
DulunduEOzelYTopalogluUTokluHErcanFGedikNSenerG. Grape seed extract reduces oxidative stress and fibrosis in experimental biliary obstruction. J Gastroenterol Hepatol2007; 22: 885–92.
139.
LiWHeHChenYTHayashidaYTsengSC. Reversal of myofibroblasts by amniotic membrane stromal extract. J Cell Physiol2008; 215: 657–64.
140.
GarrisonGHuangSKOkunishiKScottJPKumar PenkeLRScruggsAMPeters-GoldenM. Reversal of myofibroblast differentiation by prostaglandin E(2). Am J Respir Cell Mol Biol2013; 48: 550–8.
KulkarniAAThatcherTHOlsenKCMaggirwarSBPhippsRPSimePJ. PPAR-gamma ligands repress TGFbeta-induced myofibroblast differentiation by targeting the PI3K/Akt pathway: implications for therapy of fibrosis. PloS One2011; 6: e15909–e15909.
143.
Vozenin-BrotonsMCSivanVGaultNRenardCGeffrotinCDelanianSLefaixJLMartinM. Antifibrotic action of Cu/Zn SOD is mediated by TGF-beta1 repression and phenotypic reversion of myofibroblasts. Free Radic Biol Med2001; 30: 30–42.
144.
BorderWANobleNA. Transforming growth factor beta in tissue fibrosis. N Engl J Med1994; 331: 1286–92.
145.
SelmanMKingTEPardoAAmerican ThoracicS. European Respiratory S, American College of Chest P. Idiopathic pulmonary fibrosis: prevailing and evolving hypotheses about its pathogenesis and implications for therapy. Ann Intern Med2001; 134: 136–51.
146.
HeckerLJagirdarRJinTThannickalVJ. Reversible differentiation of myofibroblasts by MyoD. Exp Cell Res2011; 317: 1914–21.
147.
YangLChangNLiuXHanZZhuTLiCYangLLiL. Bone marrow-derived mesenchymal stem cells differentiate to hepatic myofibroblasts by transforming growth factor-beta1 via sphingosine kinase/sphingosine 1-phosphate (S1P)/S1P receptor axis. Am J Pathol2012; 181: 85–97.
AkramKMSamadSSpiteriMAForsythNR. Mesenchymal stem cells promote alveolar epithelial cell wound repair in vitro through distinct migratory and paracrine mechanisms. Respir Res2013; 14: 9–9.
150.
NasirGAMohsinSKhanMShamsSAliGKhanSNRiazuddinS. Mesenchymal stem cells and interleukin-6 attenuate liver fibrosis in mice. J Transl Med2013; 11: 78–78.
151.
JiangYJahagirdarBNReinhardtRLSchwartzREKeeneCDOrtiz-GonzalezXRReyesMLenvikTLundTBlackstadMDuJAldrichSLisbergALowWCLargaespadaDAVerfaillieCM. Pluripotency of mesenchymal stem cells derived from adult marrow. Nature2002; 418: 41–9.
152.
YangJDaiCLiuY. A novel mechanism by which hepatocyte growth factor blocks tubular epithelial to mesenchymal transition. J Am Soc Nephrol2005; 16: 68–78.
DuTZouXChengJWuSZhongLJuGZhuJLiuGZhuYXiaS. Human Wharton's jelly-derived mesenchymal stromal cells reduce renal fibrosis through induction of native and foreign hepatocyte growth factor synthesis in injured tubular epithelial cells. Stem Cell Res Ther2013; 4: 59–59.
155.
UenoTNakashimaADoiSKawamotoTHondaKYokoyamaYDoiTHigashiYYoriokaNKatoYKohnoNMasakiT. Mesenchymal stem cells ameliorate experimental peritoneal fibrosis by suppressing inflammation and inhibiting TGF-beta1 signaling. Kidney Int2013; 84: 297–307.
156.
LvSLiuGSunAWangJChengJWangWLiuXNieHGuanG. Mesenchymal stem cells ameliorate diabetic glomerular fibrosis in vivo and in vitro by inhibiting TGF-beta signalling via secretion of bone morphogenetic protein 7. Diab Vasc Dis Res2014; 11: 251–61.
157.
DanchukSYlostaloJHHossainFSorgeRRamseyABonvillainRWLaskyJABunnellBAWelshDAProckopDJSullivanDE. Human multipotent stromal cells attenuate lipopolysaccharide-induced acute lung injury in mice via secretion of tumor necrosis factor-alpha-induced protein 6. Stem Cell Res Ther2011; 2: 27–27.
158.
LeeJWFangXGuptaNSerikovVMatthayMA. Allogeneic human mesenchymal stem cells for treatment of E. coli endotoxin-induced acute lung injury in the ex vivo perfused human lung. Proc Natl Acad Sci USA2009; 106: 16357–62.
159.
OrtizLADutreilMFattmanCPandeyACTorresGGoKPhinneyDG. Interleukin 1 receptor antagonist mediates the antiinflammatory and antifibrotic effect of mesenchymal stem cells during lung injury. Proc Natl Acad Sci USA2007; 104: 11002–7.
160.
MoodleyYVaghjianiVChanJBalticSRyanMTchongueJSamuelCSMurthiPParoliniOManuelpillaiU. Anti-inflammatory effects of adult stem cells in sustained lung injury: a comparative study. PloS One2013; 8: e69299–e69299.
